BlackRock Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $8.98M | Buy |
108,401
+22,139
| +26% | +$1.83M | 0.01% | 1187 |
|
|
2016
Q3 | $7.98M | Buy |
86,262
+1,648
| +2% | +$152K | 0.01% | 1149 |
|
|
2016
Q2 | $6.58M | Sell |
84,614
-1,718
| -2% | -$134K | 0.01% | 1238 |
|
|
2016
Q1 | $7.12M | Sell |
86,332
-2,770
| -3% | -$228K | 0.01% | 1139 |
|
|
2015
Q4 | $9.33M | Sell |
89,102
-132
| -0.1% | -$13.8K | 0.01% | 978 |
|
|
2015
Q3 | $9.4M | Sell |
89,234
-16,055
| -15% | -$1.69M | 0.01% | 964 |
|
|
2015
Q2 | $14.4M | Sell |
105,289
-2,546
| -2% | -$348K | 0.02% | 748 |
|
|
2015
Q1 | $13.4M | Buy |
107,835
+4,655
| +5% | +$580K | 0.02% | 768 |
|
|
2014
Q4 | $9.33M | Sell |
103,180
-12,603
| -11% | -$1.14M | 0.01% | 986 |
|
|
2014
Q3 | $8.36M | Buy |
115,783
+9,902
| +9% | +$715K | 0.01% | 1031 |
|
|
2014
Q2 | $6.59M | Buy |
105,881
+46,756
| +79% | +$2.91M | 0.01% | 1221 |
|
|
2014
Q1 | $4.03M | Buy |
59,125
+4,462
| +8% | +$304K | 0.01% | 1521 |
|
|
2013
Q4 | $3.85M | Sell |
54,663
-852
| -2% | -$59.9K | 0.01% | 1527 |
|
|
2013
Q3 | $4.01M | Buy |
55,515
+11,168
| +25% | +$806K | 0.01% | 1425 |
|
|
2013
Q2 | $2.47M | Buy |
+44,347
| New | +$2.47M | ﹤0.01% | 1702 |
|